Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.720
+0.110 (4.21%)
At close: Jan 22, 2026, 4:00 PM EST
2.710
-0.010 (-0.37%)
After-hours: Jan 22, 2026, 4:00 PM EST
Aytu BioPharma Market Cap
Aytu BioPharma has a market cap or net worth of $27.71 million as of January 22, 2026. Its market cap has increased by 154.24% in one year.
Market Cap
27.71M
Enterprise Value
22.36M
1-Year Change
154.24%
Ranking
Category
Stock Price
$2.72
Market Cap Chart
Since March 31, 2015, Aytu BioPharma's market cap has increased from $200.00K to $27.71M, an increase of 13,755.96%. That is a compound annual growth rate of 57.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 26.60M | 0.38% |
| Dec 31, 2025 | 26.50M | 152.38% |
| Dec 31, 2024 | 10.50M | -33.54% |
| Dec 29, 2023 | 15.80M | 33.90% |
| Dec 30, 2022 | 11.80M | -68.95% |
| Dec 31, 2021 | 38.00M | -50.33% |
| Dec 31, 2020 | 76.50M | 278.71% |
| Dec 31, 2019 | 20.20M | 197.06% |
| Dec 31, 2018 | 6.80M | -30.61% |
| Dec 29, 2017 | 9.80M | 9,700.00% |
| Dec 30, 2016 | 100.00K | -66.67% |
| Dec 31, 2015 | 300.00K | 50.00% |
| Mar 31, 2015 | 200.00K | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |